Immunity to the ehrlichiae: New tools and recent developments

Current Opinion in Infectious Diseases

Volumn 18, Issue 3, 2005, Pages 217-221

  Winslow, Gary M ^a   Bitsaktsis, Constantine ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

CD4 T cell; CD8 T cell; Ehrlichiosis; Immunopathology

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE;

ANAPLASMA; CYTOKINE PRODUCTION; EHRLICHIA; EHRLICHIOSIS; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOCYTE; MONOCYTE; NONHUMAN; PATHOGENESIS; REVIEW; T LYMPHOCYTE;

EID: 20144370399     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000168381.86024.cf     Document Type: Review

References (32)

1. Dumler JS, Barbet AF, Bekker CP, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001; 51:2145-2165.
2. Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev 2003; 16:37-64.
3. Liddell AM, Stockham SL, Scott MA, et al. Predominance of Ehrlichia ewingii in Missouri dogs. J Clin Microbiol 2003; 41:4617-4622.
4. Stone JH, Dierberg K, Aram G, Dumler JS. Human monocytic ehrlichiosis. JAMA 2004; 292:2263-2270. A detailed analysis of a recent clinical case of HME. The affected individual was receiving an immunosuppresive drug regimen which may have contributed to his susceptibility.
5. Paddock CD, Folk SM, Shore GM, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 2001; 33:1586-1594.
6. Li JS, Winslow G. Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. Infect Immun 2003; 71:4229-4237.
7. Winslow G, Yager E, Shilo K, et al. Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. Infect Immun 1998; 66:3892-3899.
8. Ganta RR, Wilkerson MJ, Cheng C, et al. Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes. Infect Immun 2002; 70:380-388.
9. von Loewenich FD, Scorpio DG, Reischl U, et al. Frontline: control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur J Immunol 2004; 34:1789-1797.
10. Olano JP, Wen G, Feng HM, et al. Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model. Am J Pathol 2004; 165:997-1006. Unlike some other isolates, E. muris causes a nonfatal persistent infection in the mouse. Bacteria persisted for at least as long as 5 months post infection in the spleen, liver and lung. Liver pathology was relatively mild, and hepatic necrosis was largely absent. The mouse model provides an opportunity to study how the bacteria evade host immune responses over a prolonged period.
11. Sotomayor EA, Popov VL, Feng HM, et al. Animal model of fatal human monocytotropic ehrlichiosis. Am J Pathol 2001; 158:757-769.
12. Shibata S, Kawahara M, Rikihisa Y, et al. New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan. J Clin Microbiol 2000; 38:1331-1338.
13. Bulla C, Kiomi Takahira R, Pessoa Araujo J Jr, et al. The relationship between the degree of thrombocytopenia and infection with Ehrlichia canis in an endemic area. Vet Res 2004; 35:141-146. Thrombocytopenia, a characteristic of E. canis infection in dogs, was well correlated with Ehrlichia infection. This characteristic may aid in the diagnosis of the disease.
14. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-995.
15. Lin M, Rikihisa Y. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun 2003; 71:5324-5331.
16. Bitsaktsis C, Huntington J, Winslow GM. Production of Interferon-γ by CD4 T cells is essential for resolving ehrlichia infection. J Immunol 2004; 172:6894-6901. This study describes the development of a low-dose IOE infection model. The authors provide a formal demonstration that production of IFNγ by CD4 T cells is essential for resistance to low-dose IOE infection. Other data suggest that memory responses elicited by IOE may be impaired.
17. Ismail N, Soong L, McBride JW, et al. Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. J Immunol 2004; 172:1786-1800. The authors utilize a mouse model of fatal monocytic ehrlichiosis to investigate protective and pathological immune responses. Prior infection with E. muris was sufficient to provide protection against fatal IOE challenge. Other evidence suggested that inflammatory cytokine production by CD8 T cells during fatal IOE challenge contributed to immunopathology.
18. Zhang JZ, Sinha M, Luxon BA, Yu XJ. Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles. Infect Immun 2004; 72:498-507. A microarray-based analysis of transcriptional regulation in human THP-1 cells following E. chaffeensis infection. Survival strategies used by the ehrlichiae involve the suppression of genes related to cytokine expression, apoptosis and membrane trafficking.
19. Lin M, Rikihisa Y. Ehrlichia chaffeensis downregulates surface toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-kappaB, ERK 1/2 and p38 MAPK in host monocytes. Cell Microbiol 2004; 6:175-186. Evidence is provided that E. chaffeensis modulates innate receptor signaling in response to lipopolysaccharide by downregulating TLR2 and 4 and CD14 during infection of human monocytes. Downregulation may be achieved via inhibition of p38 MAPK and Erk 1/2 activities.
20. McBride JW, Yu XJ, Walker DH. Glycosylation of homologous immunodominant proteins of Ehrlichia chaffeensis and Ehrlichia canis. Infect Immun 2000; 68:13-18.
21. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002; 2:77-84.
22. Dendrivan Kooyk Y, Engering A, Lekkerkerker AN, et al. Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr Opin Immunol 2004; 16:488-493. C-type lectin receptors on dendritic cells may be exploited by bacteria such as the ehrlichiae to escape immune recognition.
23. Bell-Sakyi L. Ehrlichia ruminantium grows in cell lines from four ixodid tick genera. J Comp Pathol 2004; 130:285-293.
24. Munderloh UG, Lynch MJ, Herron MJ, et al. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet Microbiol 2004; 101:53-64. A related rickettsia, A. phagocytophila, was able to establish infection in endothelial cell lines, suggesting that endothelial cells may be targets of rickettsia infection in vivo. During tick infection bacteria do not have direct access to blood vessels, so endothelial cell infection may allow eventual dissemination into the blood stream.
25. Ganta RR, Cheng C, Wilkerson MJ, Chapes SK. Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice. Infect Immun 2004; 72:159-167. Gene-targeted mice were used to demonstrate a requirement for the CD4 co-receptor and for class II MHC during E. chaffeensis infection in the mouse.
26. Winslow GM, Yager E, Li J. Mechanisms of humoral immunity during Ehrlichia chaffeensis infection. Ann N Y Acad Sci 2003; 990:435-443.
27. Esteves I, Walravens K, Vachiery N, et al. Protective killed Ehrlichia ruminantium vaccine elicits IFN-gamma responses by CD4+ and CD8+ T lymphocytes in goats. Vet Immunol Immunopathol 2004; 98:49-57. This study and the following study support a role for IFNγ production by both CD4 and CD8 T cells elicited by vaccination during E. ruminantium infection in goats.
28. Esteves I, Vachiery N, Martinez D, Totte P. Analysis of Ehrlichia ruminantium-specific T1/T2 responses during vaccination with a protective killed vaccine and challenge of goats. Parasite Immunol 2004; 26:95-103.
29. Feng HM, Walker DH. Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis. Infect Immunol 2004; 72:966-971.
30. Li JS, Yager E, Reilly M, et al. Outer membrane protein specific monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis. J Immunol 2001; 166:1855-1862.
31. Zhang J, Guo H, Winslow G, Yu X. Expression of members of the 28-kDa major outer membrane protein family of Ehrlichia chaffeensis during persistent infection. Infect Immun 2004; 72:4336-4343. Studies of serological responses to variable outer membrane proteins suggest that many are co-expressed during persistent E. chaffeensis infection in a canine model.
32. McBride JW, Corstvet RE, Gaunt SD, et al. Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. Infect Immun 2003; 71:2516-2524.